series-a
Stage
1
Investors
About
Develops novel therapeutics that target the immune system to treat brain diseases, leveraging the interplay between the nervous and immune systems to address neurological disorders.
Explore MindImmune's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.